Delaware
|
33-0728374
|
|
(State or other jurisdiction of
|
(IRS Employer
|
|
incorporation)
|
Identification No.)
|
The information with respect to item 2.02 in this current report and its accompanying exhibit shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this current report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Dynavax, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Effective on May 1, 2011, Dynavax entered into an agreement with Baylor Research Institute under which Robert L. Coffman, Ph.D., Chief Scientific Officer of Dynavax, will provide certain research and scientific advisory services on a part-time basis to the Baylor Institute Immunology Research laboratories. As a result, Dr. Coffman's annual base salary paid by Dynavax was reduced to 80% of the current rate, effective on May 1, 2011.
Dynavax Technologies Corporation
|
||||||||
Date: May 05, 2011
|
By:
|
/s/ Michael S. Ostrach
|
||||||
Michael S. Ostrach
|
||||||||
Vice President
|
||||||||
Exhibit No.
|
Description
|
|
EX-99.1
|
Press Release, dated May 5, 2011 titled "Dynavax Reports First Quarter 2011 Financial Results."
|